标题
miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression
作者
关键词
-
出版物
CELL RESEARCH
Volume 25, Issue 4, Pages 477-495
出版商
Springer Nature
发表日期
2015-02-20
DOI
10.1038/cr.2015.23
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex
- (2014) Deshui Jia et al. HEPATOLOGY
- microRNAs miR-27a and miR-27b Directly Regulate Liver Dihydropyrimidine Dehydrogenase Expression through Two Conserved Binding Sites
- (2014) S. M. Offer et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNAs as therapeutic targets in chemoresistance
- (2013) Michela Garofalo et al. DRUG RESISTANCE UPDATES
- Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma
- (2013) Jie Ding et al. HEPATOLOGY
- Development of Therapeutic Combinations Targeting Major Cancer Signaling Pathways
- (2013) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- MicroRNAs and other non-coding RNAs as targets for anticancer drug development
- (2013) Hui Ling et al. NATURE REVIEWS DRUG DISCOVERY
- Technologies for deriving primary tumor cells for use in personalized cancer therapy
- (2013) Abhisek Mitra et al. TRENDS IN BIOTECHNOLOGY
- MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
- (2012) Sidong Huang et al. CELL
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)
- (2012) Joong-Won Park et al. LIVER INTERNATIONAL
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- miR-34 – a microRNA replacement therapy is headed to the clinic
- (2012) Andreas G. Bader Frontiers in Genetics
- Simultaneous Delivery of siRNA and Paclitaxel via a “Two-in-One” Micelleplex Promotes Synergistic Tumor Suppression
- (2011) Tian-Meng Sun et al. ACS Nano
- An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis
- (2011) Maria Hatziapostolou et al. CELL
- Cancer genomics: from discovery science to personalized medicine
- (2011) Lynda Chin et al. NATURE MEDICINE
- MicroRNA pharmacogenomics: Post-transcriptional regulation of drug response
- (2011) Jakob Lewin Rukov et al. TRENDS IN MOLECULAR MEDICINE
- MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
- (2010) Francesca Fornari et al. CANCER RESEARCH
- Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion
- (2010) Pei-Jer Chen et al. LIVER INTERNATIONAL
- Towards a knowledge-based Human Protein Atlas
- (2010) Mathias Uhlen et al. NATURE BIOTECHNOLOGY
- Targeting microRNAs in cancer: rationale, strategies and challenges
- (2010) Ramiro Garzon et al. NATURE REVIEWS DRUG DISCOVERY
- Correlations between RNA and protein expression profiles in 23 human cell lines
- (2009) Marcus Gry et al. BMC GENOMICS
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Statistical methods for analysis of high-throughput RNA interference screens
- (2009) Amanda Birmingham et al. NATURE METHODS
- EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer
- (2008) Alberto F. Sobrero et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular targeted therapies in hepatocellular carcinoma: From pre-clinical models to clinical trials
- (2008) Pippa Newell et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started